DILIP BUILDCON LTD Q4 RESULTS
Expect gradual recovery in Nifty after correction: Sanjay Parekh
Interarch is what we recently added, of course, at significantly lower levels and it has run up quite well, it is into prefab structure, it is a bottom-up stock picking that we did and there the opportunity is very-very large, unorganised to organised segment there is a shift and they are very well placed there, so which accelerates the setting up of factories and buildings that they are into and they have a very-very strong clientele.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 32% in 1 year
From another China stimulus, to the US Fed’s actions, to the US elections. The coming days will be dominated by global news flows. Add to this mix the Q2 results season – with numbers mostly below the street's expectations. So the market might see movements it is not prepared for. Given this scenario, if you are seeking to increase exposure, look for stocks where the business operating matrix is showing improvement. They tend to weather any storm better. Our selected stocks this week depict a strong upward trajectory in their overall average score which is based on five key pillars – earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
Afcons Infrastructure IPO sails through on final day of bidding. Check GMP, details
Afcons Infrastructure's IPO, a Shapoorji Pallonji company, was fully subscribed on the last day with the issue receiving bids 1.10 times the total size. The retail portion saw 52% subscription while non-institutional investors subscribed 2.42 times. The company plans to use the proceeds for construction equipment, working capital, and debt repayment.
Afcons Infrastructure IPO lags with 36% subscription on Day 2. GMP drops to 4%. Check details
Afcons Infrastructure's IPO was only 18% subscribed on day two. Analysts recommend long-term investment, citing a strong business model despite challenges like low profit margins and government dependency.
Sun Pharma Q2 Results: Profit rises 28% YoY to Rs 3,040 crore, beats estimates
Sun Pharmaceutical Q2 FY25 Results: Sun Pharma reported a 28% increase in consolidated net profit for Q2, reaching Rs 3,040 crore, up from Rs 2,375 crore last year. Revenue rose 9% YoY to Rs 13,291 crore, surpassing market estimates. EBITDA grew 24% YoY to Rs 3,939 crore, with a margin of 29.6%. Formulation sales in India increased 11% YoY to Rs 4,265 crore, representing 32% of total sales.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 46%
More than the Nifty and Sensex taking a beating, what has been bothering the street and worrying investors is the lack of market breadth these past few days. The risk of the situation getting worse if the indices remain under pressure is high. Also, with valuations still on the higher side, any recovery may take a while. In such a situation, what should bother you more? What happens in the market over the next few days or months? Or how a business is going to pan out? The business, of course. So here are select stocks that depict a strong upward trajectory in their overall average score which is based on five key pillars – earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
- Go To Page 1
Zomato captains India Inc’s dream Team XI with over 1,000% profit growth
The June quarter saw Zomato and 10 other companies achieving over 1,000% profit growth. Zomato's profit skyrocketed 12,550% year-on-year. Other remarkable performers were Shakti Pumps and Lotus Chocolate. Experts advise focusing on growth outlooks rather than past profits when making investment decisions.
Navigating Union Budget impact: Opportunities amidst overheated market
Coalition politics often requires a delicate balancing act, with the government catering to diverse interests. This could lead to a more populist Budget aimed at appealing to a wider range of voters. However, considering the Modi government's history of implementing bold reforms, we might see a mixed approach that combines populist measures with continued reform initiatives.
Q1 results, FII action among 10 factors to impact D-Street mood this week
Nifty gained 1.2%, driven by IT, energy, and pharma stocks. U.S. labor data, TCS earnings, Rupee vs. Dollar, Bank Nifty, oil prices, FIIs, IPO action, and dividends will influence markets next week. Bulls maintain strength with positive sentiment and broader market participation, expecting some consolidation.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Q4 results today: Sun Pharma, Nykaa, Paytm among 162 companies to declare earnings on Wednesday
162 companies to report Q4 earnings on Wednesday. Nykaa expects 24% BPC and Fashion GMV growth, while Paytm faces a revenue decline from RBI actions. Analysts also predict pressure from discounting and lower advertising income.
Q4 results this week: ITC, ONGC, Sun Pharma, Nykaa, Ircon International and IRFC
ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.
PNB official allegedly embezzles nearly Rs 5 Crore from Bhopal-based infrastructure company: CBI FIR
The CBI has booked a PNB official for allegedly siphoning off Rs 4.98 crore from the account of a Bhopal-based infrastructure construction company in collusion with a private person. The incident occurred at PNB's Delhi Road Branch in Hapur, Uttar Pradesh. Head cashier Mukul Singh and Vinod Kumar Singh are accused of merging the company's account with that of Star Raze and transferring the funds through internet banking, causing a loss to PNB. The CBI conducted searches and registered an FIR in this regard.
Q4 results this week: SBI, Tata Motors, L&T, Asian Paints, TVS Motor and PB Fintech
Various widely tracked companies like Tata Motors, SBI, Asian Paints, BPCL, Larsen & Toubro, Tata Power, Canara Bank, TVS Motor, Hero MotoCorp, Godrej Consumer Products, JSW Energy, Dr. Reddy's Laboratories, PB Fintech, and Bank of Baroda will be releasing their March quarter report cards this week. Here’s a list:
Q3 results this week: M&M, Coal India, Hindustan Aeronautics, Eicher motors, BHEL and IRCTC
Siemens, Hindalco Industries, Eicher Motors, BHEL, IRCTC, Bosch, Info Edge (India), Oil India, Prestige Estates Projects, Gujarat Gas, ITI, Deepak Nitrite, National Aluminium Company,
Sun Pharma Q3 Results: Cons PAT rises 17% YoY to Rs 2,561 crore; Rs 8.5/sh dividend announced
Sun Pharmaceutical Industries reported a 17.4% YoY growth in net profit for Q4, beating estimates. Consolidated revenue grew 10% YoY. The company recommended an interim dividend payout. EBITDA rose 16% YoY and margins expanded. Raw material cost fell, but staff cost increased. India formulation sales and US formulation sales grew, while emerging markets formulation sales declined.
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%
Soon after the announcement by the US Fed two weeks back, the mood on the Street has once again turned in favor of bulls. Whether it is Sensex or Nifty, the underlying bias has once again turned bullish, specially in midcap space. But one headwind remains -- valuation is still at a higher level. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies there has been a significant improvement in market outlook in the given time frame.
Q2 results this week: Adani Ports, Tata Power, LIC, RVNL, M&M and others
Power Grid, Shree Cements, Trent, Zydus Lifesciences, Info Edge (India), Indian Railway Catering & Tourism Corporation, Cummins India, Alkem Laboratories, UNO Minda, Prestige Estates Projects, among others will release their Q2 earnings on November 7
Sun Pharma Q2 Results: Cons profit rises 6% YoY to Rs 2,385 crore, beats estimates
Operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8% on year to Rs 3,179.30 crore, but operating margin contracted by 91 basis points to 26.08%. Total expenses in the quarter rose to Rs 9,695 crore, from Rs 8,625 crore a year ago.
Sun Pharma Q1 Results: Cons PAT falls 2% YoY to Rs 2,023 crore on one-time expense
The fall in the bottomline was partly due to certain one-time charges totalling Rs 323 crore. The company also incurred a one-time transitional cost of Rs 51 crore on the relocation of Alchemee operations from California to New York.
Q1 results this week: Adani Enterprises, SBI, Maruti, Titan, Airtel, M&M & others
Major firms such as Maruti Suzuki, Titan, Bharti Airtel, and M&M among others will release their June quarter results this week. The report cards of other companies such as GAIL, Power Grid, Sun Pharma, and Adani Enterprises are also expected to be out. This week, Maruti Suzuki, Adani Enterprises, Adani Transmission, Titan, IndiGo, Bharti Airtel, Sun Pharma, SBI, M&M, Varun Beverages, and Bank of Baroda are scheduled to announce their quarterly performance.
Sun Pharma Q4 Results: Firm clocks cons PAT of Rs 1,984 crore, declares Rs 4/share dividend
The company approved a final dividend of Rs 4 per equity share which will be subject to the approval of the shareholders. The total dividend payout for FY23 is Rs 11.5 per share compared to Rs 10 per share for FY22.
Sun Pharma reports Rs 1,985 crore net profit in Q4FY23
Sun Pharma posted a net profit of INR 1,985 crore ($266m) in Q4 FY23 due to increased specialty drug sales and strong growth in domestic formulations and emerging markets. The firm made a net loss of INR 2,277 crore in the same quarter of the previous year. The adjusted net profit for Q4 FY23, excluding exceptional items, was INR 2,156 crore. The company's gross revenue climbed 14.3% year-on-year to INR 10,726 crore, while its EBITDA increased 19.7% YoY to INR 2,802 crore.
Q4 results this week: LIC, Shree Cements, Vodafone Idea, Sun Pharma, M&M, Nykaa and others
Several popular companies such as ONGC, M&M, Vodafone Idea, HUDCO, Shree Cements, BPCL, LIC, Nykaa, and Hindalco among others, are expected to release their quarterly earnings report later this week. The list of companies to report their results on each day include names such as Ashok Leyland, Sun Pharma, Aditya Birla Fashion and Retail, Grasim Industries, Radico Khaitan, Finolex Industries, and Hindustan Tin Works amongst others, during the period of May 22-27.
Elections & Infrastructure: 4 construction & contract companies with ‘strong buy’ and ‘buy’ rating can rise up to 44%
Karnataka was the first state election in the series of elections which we will witness in 2023 before the general election of 2024. The government spending on infrastructure projects, which has remained at elevated levels for many years, may see a further push as many state governments rush to complete and announce more of them. This will have a trickle down effect on many parts of the economy and specially companies in contracting and construction. ET screener powered by Refinitiv’s Stock Report Plus lists down stocks with high upside potential over the next 12 months, having an average recommendation rating of “buy” or "strong buy".
Smallcap stock jumps 10% on winning Rs 780 crore order
The project is for a six-laning of 16-kilometre access-controlled Greenfield highway from Audireddipalle to Mallapalle, Bengaluru-Vijayawada Economic Corridor on HAM mode under the Bharatmala Pariyojana Phase-I in Andhra Pradesh, the company said in a filing.
Catching falling knives? Retail investors hike up to 40% stake in 12 wealth-eroders
It is followed by Future Consumer as the debt-ridden Kishore Biyani firm has tanked about 75% in the last one year. The shareholding of individual investors has jumped over 12% to 87.19% as of September 30, 2022, in the given period.
Wondering what this earnings season has in store? Check out brokers’ sector-wise preview
Margins remained pressured as companies deal with elevated attrition resulting in high retention costs and increase in travel and discretionary expenses. Infosys and TCS may perform well but many others face risk of growth downgrades, Kotak said.
Buy Dilip Buildcon, target price Rs 400: HDFC Securities
Dilip Buildcon Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 3449.94 Crore) operating in Construction sector.
Load More
